Vaccine manufacture article published in The Conversation
13 May 2020
UCL Biochemical Engineering academics Professor Martina Micheletti and Associate Professor Qasim Rafiq have published "Coronavirus vaccine: how we’re preparing to make enough for the whole world" in The Conversation
There are 102 candidate vaccines being explored as a means of ending the COVID-19 pandemic, as of April 30. Eight of these have already made it to clinical trials in humans, and another 94 are in the pre-clinical evaluation stage. Martina Micheletti, Professor of Bioprocess Fluid Dynamics and co-Director of the Future Vaccine Manufacturing Hub together with Qasim Rafiq, Associate Professor of Cell and Gene Therapy Bioprocess Engineering, have published "Coronavirus vaccine: how we’re preparing to make enough for the whole world." You can read the full article in The Conversation here
Professor Rafiq is the programme director of a Manufacture and Commercialisation of Stem Cell and Gene Therapies MSc enrolling in September 2020.
If you'd like to find out more about how vaccines are made please sign up for a free taster lecture taking place on 4 June 2020.